Use of 2-iminobiotin for the prevention or treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4188 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2419302

A selective inhibitor of neuronal nitric oxide synthase (nNOS) and of inducible nitric oxide synthase (iNOS), which does not substantially inhibit endothelial nitric oxide synthase (eNOS), can be effectively used for the treatment, in human or other mammalian neonates, of the effects of complications during childbirth. Such effects include perinatal asphyxia and hypoxia-ischemia. A very useful example of such a selective inhibitor is 2- iminobiotin.

Un inhibiteur sélectif de la synthase d'oxyde nitrique (nNOS) et de la synthase d'oxyde nitrique inductible (iNOS), qui n'inhibe pas sensiblement la synthase d'oxyde nitrique endothéliale (eNOS) peut être utilisé efficacement pour le traitement, chez l'humain ou d'autres nouveau-nés mammaliens, des effets des complications liées à la naissance. Ces effets comprennent l'asphyxie périnatale et l'hypoxie-ischémie. Un exemple très utile de cet inhibiteur sélectif est la 2-iminobiotine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of 2-iminobiotin for the prevention or treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 2-iminobiotin for the prevention or treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 2-iminobiotin for the prevention or treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1648406

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.